 Proactive Investors USA & Canada |
Glaxo to Hike Stake in Theravance
Zacks.com The increased holding by the pharma major reflects its confidence in the Relovair program, under which the companies are looking to replace one of Glaxo's best selling drugs Advair by evaluating treatment options for asthma and chronic obstructive … GlaxoSmithKline Boosts Stake In Theravance To 27% GlaxoSmithKline to Increase Its Ownership in Theravance Glaxo Lifts Theravance Stake |
View full post on asthma – Google News